search
Back to results

iACT for PTSD and Chronic Pain : a Development Pilot Series

Primary Purpose

PTSD, Chronic Pain

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Internet-delivered ACT for PTSD and chronic pain
Sponsored by
Skane University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for PTSD focused on measuring PTSD, Chronic pain

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • a CAPS of ≥25
  • subjected to single traumatic events
  • were able to understand Swedish
  • had symptoms of chronic pain that interfered significantly with everyday life
  • were fully examined medically and had received medical treatment if indicated
  • were able to be an active part of the rehabilitation process, regain functioning in different life areas and participate in treatment interventions for approximately 5 hours every week
  • stable dose of medication
  • able to read and write in Swedish
  • had access to a smart phone or computer with internet access

Exclusion Criteria:

  • repeated and extensive traumatic events
  • had other acute or severe psychiatric disorders or symptoms that warranted designation as the primary disorder (ongoing substance dependence, untreated bipolar disorder, OCD, psychotic symptoms, severe depression)
  • were actively abusing analgesic medications (including narcotics), alcohol or other drugs
  • had great difficulty to harbour and handle strong emotions that could lead to emotional outbursts or self-harming behavior
  • had health risks due to medical reasons;
  • had social or economic difficulties or lack of social support that hindered behavior change
  • current severe suicidal ideation that warranted immediate intervention (indicated by the MINI and a score of 3 to item 9 of the Patient Health Questionnaire 9-item version (PHQ9))

Sites / Locations

  • Department of Pain Pehabilitation, Skåne University Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Treatment

Arm Description

Internet delivered Acceptance and Commitment Therapy for PTSD and Chronic Pain, supported by a psychologist

Outcomes

Primary Outcome Measures

PTSD diagnostic status as measured by the Clinician-Administered PTSD Scale (CAPS)
(changes between assessments) The scale assesses the presence of the DSM-5 PTSD criteria A-J.
PTSD symptom severity as measured by the the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) and the Life Events Checklist (LEC-5)
(changes between assessments) The scale ranges from 0-80 and higher sores indicate greater severity of PTSD symptoms.

Secondary Outcome Measures

Anxiety and depression as measured by the Hospital Anxiety and Depression Scale (HADS)
(changes between assessments) The subscales range from 0-21 and higher scores corresponds to greater severity of depression/anxiety.
Psychological inflexibility as measured by the Psychological Inflexibility in Pain Scale (PIPS)
(changes between assessments) The scale ranges from 12-84 and higher scores corresponds to greater psychological inflexibility.
Acceptance as measured by the Chronic Pain Acceptance Questionnaire-8 (CPAQ-8)
(changes between assessments) The scale ranges from 0-48 and higher scores corresponds to greater acceptance.
Posttraumatic Cognitions as measured by the Posttraumatic Cognitions Inventory (PTCI)
(changes between assessments) The scale ranges from 33-231 and higher scores corresponds to greater endorsement of trauma-related thoughts and beliefs.
Pain interference as measured by the Multidimensional Pain Inventory (MPI)
(changes between assessments) The scales ranges from 0-6 and higher scores corresponds to greater pain interference.
Pain intensity as measured by the Numerical Rating Scale (NRPS)
(changes between assessments) The scale ranges from 0-10 and higher scores corresponds to greater pain intensity.
Pain catastrophizing as measured by the Pain Catastrophizing Questionnaire (PCS)
(changes between assessments) The scale ranges from 0-52 and higher scores represent greater pain catastrophizing.
Perceived health as measured by the RAND-36 Measure of Health-Related Quality of Life (RAND-36)
(changes between assessments) Each subscale is directly transformed into a 0-100 scale where higher scores correspond to greater levels on that specific subscale.
Kinesiophobia as measured by the Tampa Scale of Kinesiophobia (Tampa)
(changes between assessments) The scale ranges from 17-68 and higher scores represent greater levels of kinesiophobia.
Number of adverse events reported by the participant
Health care utilization, pharmaeconomics, medication use, and return to work as measured by the MiDAS-database of the Swedish Social Insurance Agency, the Swedish Prescribed Drug Register and health-care database of Region Skåne
(changes between assessments)

Full Information

First Posted
February 20, 2020
Last Updated
October 31, 2022
Sponsor
Skane University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04306809
Brief Title
iACT for PTSD and Chronic Pain : a Development Pilot Series
Official Title
Internet-delivered ACT for PTSD and Chronic Pain : a Development Pilot Series
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
August 1, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
March 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Skane University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary aim of this study is to investigate the effect of Internet-delivered Acceptance and commitment therapy for PTSD and comorbid chronic pain. First, a pilot study (no randomization; N=10) will be conducted to test the intervention and assessment procedures. This will be followed by a randomized controlled trial with waitlist control. The participants will go through an active internet-based ACT treatment focused on education about PTSD, value-based exposure for the traumatic memory and avoided situations, and behavior change through exercises targeting the processes mindfulness, cognitive defusion and acceptance. The treatment is delivered on a safe internet platform. Participants have planned telephone contact with their assigned psychologist 3 times during the program and can also contact their psychologist via a message system in the platform and expect answer within 48 hours.
Detailed Description
Objective: The primary aim of this study is to investigate the effect of Internet-delivered Acceptance and commitment therapy (iACT) for PTSD and comorbid chronic pain. Sample size: 10 participants. Trial design: All participants are offered treatment. Participants are recruited from the Pain Rehabilitation Unit at Skåne University Hospital. The unit is a government supported, regional specialist center focused on assessment and treatment of chronic pain and related disability. Assessments: Baseline and post treatment (2 weeks after treatment) assessments will be conducted by an assessor who is trained to administer the study measures. Self-report measures will also collected at this time, post treatment (2 weeks after treatment) as well as during a 3-month follow up. Assessment includes: Pre-and post assessment: Assessors will collect demographic information, self-report measures, and trauma history. During the pre- and post-assessment the Clinician-Administered PTSD Scale for DSM-5 will be administered to establish PTSD whether participants met the DSM-5 criteria for PTSD. During the pre-assessment the Mini International Neuropsychiatric Interview 5.0 (MINI) will be administered to detect the presence of other comorbid disorders and assess inclusion criteria and rule out exclusion criteria. Post-treatment exit interview: At the post-assessment, the assigned assessor will ask participants about their satisfaction with and experience of the program, what they found helpful or unhelpful and suggestions for future improvements. During treatment: During treatment the treatment credibility scale will be administered to assess the patients' perceptions of how credible the treatment is following the introduction of the treatment rationale and the main treatment components (included in the internet program). Safety parameters: As a mean to monitor safety and progress participants complete two self-report measures within the program (PTSD Checklist for DSM-5 [PCL-5] and Hospital anxiety and depression scale [HADS] twice during the program and the therapist can follow these scores. In addition, participants can report any adverse events during treatment, at post treatment and follow-up assessment. Data collection: Self-report measures will be mailed to participants Main statistical analysis: Between-group estimates on outcome will be conducted using repeated measurements. The analyses will be conducted using intention to treat principles and post hoc comparisons.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
PTSD, Chronic Pain
Keywords
PTSD, Chronic pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment
Arm Type
Experimental
Arm Description
Internet delivered Acceptance and Commitment Therapy for PTSD and Chronic Pain, supported by a psychologist
Intervention Type
Behavioral
Intervention Name(s)
Internet-delivered ACT for PTSD and chronic pain
Intervention Description
The participants will go through an active internet-based ACT treatment focused on education about PTSD, value-based exposure for the traumatic memory and avoided situations, and behavior change through exercises targeting the processes mindfulness, cognitive defusion and acceptance. The treatment is delivered on a safe internet platform. Participants have planned telephone contact with their assigned psychologist 3 times during the program and can also contact their psychologist via a message system in the platform and expect answer within 48 hours.
Primary Outcome Measure Information:
Title
PTSD diagnostic status as measured by the Clinician-Administered PTSD Scale (CAPS)
Description
(changes between assessments) The scale assesses the presence of the DSM-5 PTSD criteria A-J.
Time Frame
Baseline, two-week-post treatment.
Title
PTSD symptom severity as measured by the the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) and the Life Events Checklist (LEC-5)
Description
(changes between assessments) The scale ranges from 0-80 and higher sores indicate greater severity of PTSD symptoms.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Secondary Outcome Measure Information:
Title
Anxiety and depression as measured by the Hospital Anxiety and Depression Scale (HADS)
Description
(changes between assessments) The subscales range from 0-21 and higher scores corresponds to greater severity of depression/anxiety.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Title
Psychological inflexibility as measured by the Psychological Inflexibility in Pain Scale (PIPS)
Description
(changes between assessments) The scale ranges from 12-84 and higher scores corresponds to greater psychological inflexibility.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Title
Acceptance as measured by the Chronic Pain Acceptance Questionnaire-8 (CPAQ-8)
Description
(changes between assessments) The scale ranges from 0-48 and higher scores corresponds to greater acceptance.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Title
Posttraumatic Cognitions as measured by the Posttraumatic Cognitions Inventory (PTCI)
Description
(changes between assessments) The scale ranges from 33-231 and higher scores corresponds to greater endorsement of trauma-related thoughts and beliefs.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Title
Pain interference as measured by the Multidimensional Pain Inventory (MPI)
Description
(changes between assessments) The scales ranges from 0-6 and higher scores corresponds to greater pain interference.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Title
Pain intensity as measured by the Numerical Rating Scale (NRPS)
Description
(changes between assessments) The scale ranges from 0-10 and higher scores corresponds to greater pain intensity.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Title
Pain catastrophizing as measured by the Pain Catastrophizing Questionnaire (PCS)
Description
(changes between assessments) The scale ranges from 0-52 and higher scores represent greater pain catastrophizing.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Title
Perceived health as measured by the RAND-36 Measure of Health-Related Quality of Life (RAND-36)
Description
(changes between assessments) Each subscale is directly transformed into a 0-100 scale where higher scores correspond to greater levels on that specific subscale.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Title
Kinesiophobia as measured by the Tampa Scale of Kinesiophobia (Tampa)
Description
(changes between assessments) The scale ranges from 17-68 and higher scores represent greater levels of kinesiophobia.
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.
Title
Number of adverse events reported by the participant
Time Frame
2-week-post treatment.
Title
Health care utilization, pharmaeconomics, medication use, and return to work as measured by the MiDAS-database of the Swedish Social Insurance Agency, the Swedish Prescribed Drug Register and health-care database of Region Skåne
Description
(changes between assessments)
Time Frame
Baseline, two-week-post treatment, 3 month-follow-up.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: a CAPS of ≥25 subjected to single traumatic events were able to understand Swedish had symptoms of chronic pain that interfered significantly with everyday life were fully examined medically and had received medical treatment if indicated were able to be an active part of the rehabilitation process, regain functioning in different life areas and participate in treatment interventions for approximately 5 hours every week stable dose of medication able to read and write in Swedish had access to a smart phone or computer with internet access Exclusion Criteria: repeated and extensive traumatic events had other acute or severe psychiatric disorders or symptoms that warranted designation as the primary disorder (ongoing substance dependence, untreated bipolar disorder, OCD, psychotic symptoms, severe depression) were actively abusing analgesic medications (including narcotics), alcohol or other drugs had great difficulty to harbour and handle strong emotions that could lead to emotional outbursts or self-harming behavior had health risks due to medical reasons; had social or economic difficulties or lack of social support that hindered behavior change current severe suicidal ideation that warranted immediate intervention (indicated by the MINI and a score of 3 to item 9 of the Patient Health Questionnaire 9-item version (PHQ9))
Facility Information:
Facility Name
Department of Pain Pehabilitation, Skåne University Hospital
City
Lund
State/Province
Sverige
ZIP/Postal Code
22241
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

iACT for PTSD and Chronic Pain : a Development Pilot Series

We'll reach out to this number within 24 hrs